Výsledky vyhledávání - "Francisco Arregui Montoya"

Cambios en el tratamiento y disminución de la mortalidad del síndrome aórtico agudo. Lecciones del Registro Español del Síndrome Aórtico Agudo (RESA)

Autor: Artur Evangelista Masip, Ángela López-Sainz, Antonio José Barros Membrilla, Francisco Calvo Iglesias, Jordi López Ayerbe, Manel Azqueta Molluna, Víctor X. Mosquera Rodríguez, Francisco Arregui Montoya, Rubén Tarrío Fernández, Ana Revilla Orodea, Violeta Sánchez Sánchez, Eva María Cantero Pérez, Carlos Ferrera, David Toral Sepúlveda, Francisco Nistal, Covadonga Fernández Golfín, Augusto Sao, José Rodríguez-Palomares

Publikováno v: Revista Española de Cardiología. 75:817-825

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::52dc8482a59bf972a7e7fd893a1ced9e
https://doi.org/10.1016/j.recesp.2022.01.014

Zobrazit plný text záznamu

Spanish Registry of Acute Aortic Syndrome (RESA). Changes in therapeutic management and lower mortality in acute aortic syndrome

Publikováno v: Revista espanola de cardiologia (English ed.). 75(10)

The Spanish Registry of Acute Aortic Syndrome (RESA) was launched in 2005 to identify the characteristics of acute aortic syndrome (AAS) in Spain. The aim of this study was to analyze the differences in management and mortality in the 3 RESA iteratio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d33434f23f10cc4c073c90691d36e2d
https://pubmed.ncbi.nlm.nih.gov/35527170

Zobrazit plný text záznamu

Prevalencia e implicación pronóstica de la enfermedad valvular en pacientes con fibrilación auricular que inician anticoagulantes orales

Autor: Helena Albendín Iglesias, Ginés Elvira Ruiz, Alejandro Navarro, Juan José Cerezo Manchado, Pedro Flores Blanco, Domingo A. Pascual Figal, Sergio Manzano Fernández, César Caro Martínez, José Luis Bailén Lorenzo, Arcadio García Alberola, Francisco Arregui Montoya

Publikováno v: Revista Española de Cardiología. 72:935-943

Resumen Introduccion y objetivos La enfermedad valvular en los pacientes con fibrilacion auricular incluidos en los ensayos clinicos con anticoagulantes orales directos (ACOD) es frecuente y se asocia con peor pronostico. El objetivo es evaluar la pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4eebe1828c5466de02140f23c54c2d13
https://doi.org/10.1016/j.recesp.2018.08.006

Zobrazit plný text záznamu

Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non‐vitamin K antagonists

Autor: César Caro Martínez, Helena Albendín Iglesias, Domingo A. Pascual Figal, Francisco Arregui Montoya, José Luis Bailén Lorenzo, Arcadio García Alberola, Pedro Flores Blanco, Juan José Cerezo Manchado, Ginés Elvira Ruiz, Alejandro Navarro, Sergio Manzano-Fernández

Publikováno v: European Journal of Clinical Investigation. 49

Background Antiplatelet therapy (APT) use in combination with oral anticoagulation is common among patients with atrial fibrillation, but there is scarce information regarding its effect on outcomes in patients on non-vitamin K antagonist oral antico

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96e21fdb8f64b3ebcaa6f37bc68e8bfb
https://doi.org/10.1111/eci.13161

Zobrazit plný text záznamu

Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry

Autor: Alejandro Navarro, Pedro Flores Blanco, José Luis Bailén Lorenzo, Sergio Manzano-Fernández, Arcadio García Alberola, José Miguel Andreu Cayuelas, Domingo A. Pascual Figal, Juan José Cerezo-Manchado, Begoña Navarro-Almenzar, Ginés Elvira Ruiz, Faustino García-Candel, Almudena Cascales, César Caro-Martínez, Francisco Arregui Montoya

Publikováno v: Current medical research and opinion. 35(12)

Aim: To analyse the effectiveness and safety of DOAC (direct oral anticoagulants) in non-valvular atrial fibrillation (NVAF) patients attending clinical practice.Methods: Retrospective study of AF ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb42ecd43843d2094ad724018e4ec06
https://pubmed.ncbi.nlm.nih.gov/31335222

Zobrazit plný text záznamu

Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry

Autor: Pedro Flores Blanco, Begoña Navarro-Almenzar, Faustino García-Candel, Sergio Manzano Fernández, Juan José Cerezo Manchado, José Luis Bailén Lorenzo, César Caro Martínez, Domingo A. Pascual Figal, Francisco Arregui Montoya, Helena Albendín Iglesias, Ginés Elvira Ruiz, Arcadio García Alberola, Alejandro Navarro

Publikováno v: Current medical research and opinion. 35(8)

Objective: To ascertain the clinical profile, management and rates of thromboembolic and bleeding complications in a contemporary cohort of patients with nonvalvular atrial fibrillation (NVAF) on r...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da60cda3bf7b0452ffa027d88e34e2e
https://pubmed.ncbi.nlm.nih.gov/31148486

Zobrazit plný text záznamu

Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants

Autor: Juan José Cerezo Manchado, Arcadio García Alberola, José Luis Bailén Lorenzo, Sergio Manzano Fernández, Ginés Elvira Ruiz, Pedro Flores Blanco, Francisco Arregui Montoya, Helena Albendín Iglesias, César Caro Martínez, Alejandro Navarro, Domingo A. Pascual Figal

Publikováno v: Revista espanola de cardiologia (English ed.). 72(11)

Valvular heart disease in patients with atrial fibrillation included in clinical trials with direct oral anticoagulants (DOAC) is common and is associated with worse prognosis. The aim of this study was to evaluate the prevalence of valvular heart di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29525506377aa30e22c1d68be5dd2709
https://pubmed.ncbi.nlm.nih.gov/30497945

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání